SOMERSET, N.J., March 31, 2016 -- MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced it’s providing its leading e-prescribing solution free of charge for a limited period of time to physicians who have yet to implement an e-prescribing solution in the wake of New York’s new e-prescribing mandate.
“As of this week, New York’s I-STOP law took effect for all New York physicians and pharmacists,” said Amritpal Deol, MTBC General Counsel. She added, “I-STOP, which marks the beginning of a national trend, requires that all prescriptions be issued electronically, thereby rendering the paper prescription pad a relic of a bygone era.”
As part of MTBC’s I-STOP promotion, New York physicians who signup for MTBC’s e-prescribing by May 1, 2016, are entitled to use MTBC eRx free of charge for one year. This promotional offer is limited to 5 physicians per practice and only available to the first 500 physicians who contact MTBC.
MTBC eRx, MTBC’s proprietary electronic prescribing solution, is fully integrated with PracticeProTM, which includes a certified web-based EHR, practice management and revenue cycle management system. MTBC’s proprietary e-prescribing solution is available as an app, MTBC iRx, for Apple and Android users and an app for Apple Watch.
All of MTBC e-prescribe solutions are Surescripts® White Coat certified and facilitate controlled substances electronic prescribing through integration with EPCS Gold 2.0 by DrFirst®.
To learn more about MTBC, please visit www.mtbc.com.
About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
Press Contact: Amritpal Deol, Vice President and General Counsel MTBC [email protected] (732) 873-5133 x 141


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



